Certified by Founder Lodge
QurAlis
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $88,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes of the
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 10 ,2023 | Series B | $88,000,000 |
Dolby Family Ventures
EQT Life Sciences
Inkef
Droia Ventures
Mission Bay Capital
Mitsui & Co. Global Investment Ltd.
Dementia Discovery Fund (DDF)
Mission BioCapital
LS Polaris Innovation Fund
ALS Investment Fund
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)